Fundz

Drug Maker Innogen Closes $120M To Tap Into China’S Diabetes Market

PRIVATEDec 23, 2021

Amount Raised

$120 Million

Round Type

Funding Round

United KingdomManufacturingHealth CareScience And Engineering

Description

Chinese drug maker Innogen Pharmaceutical Technology has raised $120 million in a new funding round to speed up the development and clinical trials of drug candidates, as well as the construction of its production base.

Quick answer

Innogen raised $120 Million in a Funding Round round, dated December 23, 2021. Innogen is based in United Kingdom.

How much did Innogen raise?
Innogen raised $120 Million in a Funding Round round on December 23, 2021.
Where is Innogen based and how big is it?
Innogen is based in United Kingdom.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Manufacturing around the same time

Companies in the same sectors as Innogen that raised within 45 days of this round, from Fundz verified event records.

  • Enable Injections raised $150M on February 3, 2022.
  • Enable Injections raised $215M (Funding Round) on January 27, 2022.
  • Advanced NanoTherapies raised $9.2M on January 26, 2022.
  • Co-Diagnostics, Inc. raised $47M on January 14, 2022.
  • AnHeart Therapeutics raised $61M (Series B) on December 14, 2021.
  • Amarna Therapeutics raised $5.4M (Funding Round) on December 1, 2021.

Who to call at Innogen, and when

A new round usually means Innogen is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Innogen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Innogen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Innogen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Innogen

Location

United Kingdom

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Innogen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Innogen's next move

See what Strategic adds

Innogen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.